Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling

Takashi Kohno, Toshihisa Anzai, Kotaro Naito, Taku Miyasho, Minoru Okamoto, Hiroshi Yokota, Shingo Yamada, Yuichiro Maekawa, Toshiyuki Takahashi, Tsutomu Yoshikawa, Akitoshi Ishizaka, Satoshi Ogawa

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Aims: High-mobility group box 1 protein (HMGB1) is one of the recently defined damage-associated molecular pattern molecules derived from necrotic cells and activated macrophages. We investigated clinical implications of serum HMGB1 elevation in patients with acute myocardial infarction (MI). Then, we evaluated the effect of HMGB1 blockade on post-MI left ventricular (LV) remodelling in a rat MI model. Methods and results: Serum HMGB1 levels were examined in patients with ST-elevation MI (n = 35). A higher peak serum HMGB1 level was associated with pump failure, cardiac rupture, and in-hospital cardiac death. Then, an experimental MI model was induced in male Wistar rats. The mRNA and protein expression of HMGB1 were increased in the infarcted area compared with those values observed in sham-operated rats. We administered neutralizing anti-HMGB1 antibody (MI/anti-H) or control antibody (MI/C) to MI rats subcutaneously for 7 days. The mRNA levels of tumour necrosis factor-α and interleukin-1β and the number of macrophages in the infarcted area were reduced on day 3 in MI/anti-H rats compared with MI/C rats. Interestingly, HMGB1 blockade resulted in thinning and expansion of the infarct scar and marked hypertrophy of the non-infarcted area on day 14. Conclusion: Elevated serum HMGB1 levels were associated with adverse clinical outcomes in patients with MI. However, HMGB1 blockade in a rat MI model aggravated LV remodelling, possibly through impairment of the infarct-healing process. HMGB1, a novel predictor of adverse clinical outcomes after MI, may have an essential role in the appropriate healing process after MI.

Original languageEnglish
Pages (from-to)565-573
Number of pages9
JournalCardiovascular Research
Volume81
Issue number3
DOIs
Publication statusPublished - 2009 Feb

Fingerprint

HMGB1 Protein
Ventricular Remodeling
Infarction
Myocardial Infarction
Serum
Macrophages
Heart Rupture
Messenger RNA
Antibodies
Interleukin-1
Hypertrophy
Cicatrix

Keywords

  • Cytokines
  • Heart failure
  • Infarction
  • Infection/inflammation
  • Remodelling

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology

Cite this

Kohno, T., Anzai, T., Naito, K., Miyasho, T., Okamoto, M., Yokota, H., ... Ogawa, S. (2009). Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovascular Research, 81(3), 565-573. https://doi.org/10.1093/cvr/cvn291

Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. / Kohno, Takashi; Anzai, Toshihisa; Naito, Kotaro; Miyasho, Taku; Okamoto, Minoru; Yokota, Hiroshi; Yamada, Shingo; Maekawa, Yuichiro; Takahashi, Toshiyuki; Yoshikawa, Tsutomu; Ishizaka, Akitoshi; Ogawa, Satoshi.

In: Cardiovascular Research, Vol. 81, No. 3, 02.2009, p. 565-573.

Research output: Contribution to journalArticle

Kohno, T, Anzai, T, Naito, K, Miyasho, T, Okamoto, M, Yokota, H, Yamada, S, Maekawa, Y, Takahashi, T, Yoshikawa, T, Ishizaka, A & Ogawa, S 2009, 'Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling', Cardiovascular Research, vol. 81, no. 3, pp. 565-573. https://doi.org/10.1093/cvr/cvn291
Kohno, Takashi ; Anzai, Toshihisa ; Naito, Kotaro ; Miyasho, Taku ; Okamoto, Minoru ; Yokota, Hiroshi ; Yamada, Shingo ; Maekawa, Yuichiro ; Takahashi, Toshiyuki ; Yoshikawa, Tsutomu ; Ishizaka, Akitoshi ; Ogawa, Satoshi. / Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. In: Cardiovascular Research. 2009 ; Vol. 81, No. 3. pp. 565-573.
@article{8ed4c9b4c2e0478ca0bb5aa370b7c01f,
title = "Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling",
abstract = "Aims: High-mobility group box 1 protein (HMGB1) is one of the recently defined damage-associated molecular pattern molecules derived from necrotic cells and activated macrophages. We investigated clinical implications of serum HMGB1 elevation in patients with acute myocardial infarction (MI). Then, we evaluated the effect of HMGB1 blockade on post-MI left ventricular (LV) remodelling in a rat MI model. Methods and results: Serum HMGB1 levels were examined in patients with ST-elevation MI (n = 35). A higher peak serum HMGB1 level was associated with pump failure, cardiac rupture, and in-hospital cardiac death. Then, an experimental MI model was induced in male Wistar rats. The mRNA and protein expression of HMGB1 were increased in the infarcted area compared with those values observed in sham-operated rats. We administered neutralizing anti-HMGB1 antibody (MI/anti-H) or control antibody (MI/C) to MI rats subcutaneously for 7 days. The mRNA levels of tumour necrosis factor-α and interleukin-1β and the number of macrophages in the infarcted area were reduced on day 3 in MI/anti-H rats compared with MI/C rats. Interestingly, HMGB1 blockade resulted in thinning and expansion of the infarct scar and marked hypertrophy of the non-infarcted area on day 14. Conclusion: Elevated serum HMGB1 levels were associated with adverse clinical outcomes in patients with MI. However, HMGB1 blockade in a rat MI model aggravated LV remodelling, possibly through impairment of the infarct-healing process. HMGB1, a novel predictor of adverse clinical outcomes after MI, may have an essential role in the appropriate healing process after MI.",
keywords = "Cytokines, Heart failure, Infarction, Infection/inflammation, Remodelling",
author = "Takashi Kohno and Toshihisa Anzai and Kotaro Naito and Taku Miyasho and Minoru Okamoto and Hiroshi Yokota and Shingo Yamada and Yuichiro Maekawa and Toshiyuki Takahashi and Tsutomu Yoshikawa and Akitoshi Ishizaka and Satoshi Ogawa",
year = "2009",
month = "2",
doi = "10.1093/cvr/cvn291",
language = "English",
volume = "81",
pages = "565--573",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling

AU - Kohno, Takashi

AU - Anzai, Toshihisa

AU - Naito, Kotaro

AU - Miyasho, Taku

AU - Okamoto, Minoru

AU - Yokota, Hiroshi

AU - Yamada, Shingo

AU - Maekawa, Yuichiro

AU - Takahashi, Toshiyuki

AU - Yoshikawa, Tsutomu

AU - Ishizaka, Akitoshi

AU - Ogawa, Satoshi

PY - 2009/2

Y1 - 2009/2

N2 - Aims: High-mobility group box 1 protein (HMGB1) is one of the recently defined damage-associated molecular pattern molecules derived from necrotic cells and activated macrophages. We investigated clinical implications of serum HMGB1 elevation in patients with acute myocardial infarction (MI). Then, we evaluated the effect of HMGB1 blockade on post-MI left ventricular (LV) remodelling in a rat MI model. Methods and results: Serum HMGB1 levels were examined in patients with ST-elevation MI (n = 35). A higher peak serum HMGB1 level was associated with pump failure, cardiac rupture, and in-hospital cardiac death. Then, an experimental MI model was induced in male Wistar rats. The mRNA and protein expression of HMGB1 were increased in the infarcted area compared with those values observed in sham-operated rats. We administered neutralizing anti-HMGB1 antibody (MI/anti-H) or control antibody (MI/C) to MI rats subcutaneously for 7 days. The mRNA levels of tumour necrosis factor-α and interleukin-1β and the number of macrophages in the infarcted area were reduced on day 3 in MI/anti-H rats compared with MI/C rats. Interestingly, HMGB1 blockade resulted in thinning and expansion of the infarct scar and marked hypertrophy of the non-infarcted area on day 14. Conclusion: Elevated serum HMGB1 levels were associated with adverse clinical outcomes in patients with MI. However, HMGB1 blockade in a rat MI model aggravated LV remodelling, possibly through impairment of the infarct-healing process. HMGB1, a novel predictor of adverse clinical outcomes after MI, may have an essential role in the appropriate healing process after MI.

AB - Aims: High-mobility group box 1 protein (HMGB1) is one of the recently defined damage-associated molecular pattern molecules derived from necrotic cells and activated macrophages. We investigated clinical implications of serum HMGB1 elevation in patients with acute myocardial infarction (MI). Then, we evaluated the effect of HMGB1 blockade on post-MI left ventricular (LV) remodelling in a rat MI model. Methods and results: Serum HMGB1 levels were examined in patients with ST-elevation MI (n = 35). A higher peak serum HMGB1 level was associated with pump failure, cardiac rupture, and in-hospital cardiac death. Then, an experimental MI model was induced in male Wistar rats. The mRNA and protein expression of HMGB1 were increased in the infarcted area compared with those values observed in sham-operated rats. We administered neutralizing anti-HMGB1 antibody (MI/anti-H) or control antibody (MI/C) to MI rats subcutaneously for 7 days. The mRNA levels of tumour necrosis factor-α and interleukin-1β and the number of macrophages in the infarcted area were reduced on day 3 in MI/anti-H rats compared with MI/C rats. Interestingly, HMGB1 blockade resulted in thinning and expansion of the infarct scar and marked hypertrophy of the non-infarcted area on day 14. Conclusion: Elevated serum HMGB1 levels were associated with adverse clinical outcomes in patients with MI. However, HMGB1 blockade in a rat MI model aggravated LV remodelling, possibly through impairment of the infarct-healing process. HMGB1, a novel predictor of adverse clinical outcomes after MI, may have an essential role in the appropriate healing process after MI.

KW - Cytokines

KW - Heart failure

KW - Infarction

KW - Infection/inflammation

KW - Remodelling

UR - http://www.scopus.com/inward/record.url?scp=59449099249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59449099249&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvn291

DO - 10.1093/cvr/cvn291

M3 - Article

C2 - 18984601

AN - SCOPUS:59449099249

VL - 81

SP - 565

EP - 573

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 3

ER -